nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0806	0.104	CbGbCtD
Cefotaxime—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0718	0.0923	CbGbCtD
Cefotaxime—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0694	0.0892	CbGbCtD
Cefotaxime—SLC15A2—Ramipril—type 2 diabetes mellitus	0.064	0.0823	CbGbCtD
Cefotaxime—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0619	0.0795	CbGbCtD
Cefotaxime—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0611	0.0785	CbGbCtD
Cefotaxime—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0552	0.0709	CbGbCtD
Cefotaxime—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0526	0.0676	CbGbCtD
Cefotaxime—SLC22A7—Glyburide—type 2 diabetes mellitus	0.046	0.0592	CbGbCtD
Cefotaxime—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0413	0.053	CbGbCtD
Cefotaxime—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0383	0.0492	CbGbCtD
Cefotaxime—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0355	0.0457	CbGbCtD
Cefotaxime—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0341	0.0438	CbGbCtD
Cefotaxime—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.029	0.0373	CbGbCtD
Cefotaxime—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0196	0.0252	CbGbCtD
Cefotaxime—SLC22A6—Losartan—type 2 diabetes mellitus	0.0179	0.023	CbGbCtD
Cefotaxime—Cefazolin—PON1—type 2 diabetes mellitus	0.000925	0.61	CrCbGaD
Cefotaxime—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.000867	0.0795	CbGeAlD
Cefotaxime—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000817	0.0749	CbGeAlD
Cefotaxime—SLC22A11—kidney—type 2 diabetes mellitus	0.000762	0.0698	CbGeAlD
Cefotaxime—SLC22A7—kidney—type 2 diabetes mellitus	0.000744	0.0682	CbGeAlD
Cefotaxime—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.000742	0.068	CbGeAlD
Cefotaxime—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000725	0.0664	CbGeAlD
Cefotaxime—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.0007	0.0641	CbGeAlD
Cefotaxime—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.00068	0.0623	CbGeAlD
Cefotaxime—SLC15A1—kidney—type 2 diabetes mellitus	0.000598	0.0548	CbGeAlD
Cefotaxime—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000489	0.0448	CbGeAlD
Cefotaxime—SLC22A11—liver—type 2 diabetes mellitus	0.000482	0.0441	CbGeAlD
Cefotaxime—SLC22A7—liver—type 2 diabetes mellitus	0.00047	0.0431	CbGeAlD
Cefotaxime—SLC15A2—retina—type 2 diabetes mellitus	0.000452	0.0414	CbGeAlD
Cefotaxime—SLC22A8—kidney—type 2 diabetes mellitus	0.00043	0.0394	CbGeAlD
Cefotaxime—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000425	0.039	CbGeAlD
Cefotaxime—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000419	0.0384	CbGeAlD
Cefotaxime—SLC15A1—liver—type 2 diabetes mellitus	0.000378	0.0346	CbGeAlD
Cefotaxime—SLC15A2—kidney—type 2 diabetes mellitus	0.000374	0.0342	CbGeAlD
Cefotaxime—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000364	0.0333	CbGeAlD
Cefotaxime—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000332	0.00183	CcSEcCtD
Cefotaxime—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000328	0.0018	CcSEcCtD
Cefotaxime—Angioedema—Glyburide—type 2 diabetes mellitus	0.000326	0.00179	CcSEcCtD
Cefotaxime—Nausea—Acarbose—type 2 diabetes mellitus	0.000325	0.00179	CcSEcCtD
Cefotaxime—Pain—Glipizide—type 2 diabetes mellitus	0.000323	0.00178	CcSEcCtD
Cefotaxime—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000323	0.00178	CcSEcCtD
Cefotaxime—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000319	0.00175	CcSEcCtD
Cefotaxime—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000318	0.00175	CcSEcCtD
Cefotaxime—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000315	0.00173	CcSEcCtD
Cefotaxime—Nausea—Nateglinide—type 2 diabetes mellitus	0.000314	0.00172	CcSEcCtD
Cefotaxime—Shock—Bromocriptine—type 2 diabetes mellitus	0.000313	0.00172	CcSEcCtD
Cefotaxime—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000313	0.00172	CcSEcCtD
Cefotaxime—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000311	0.00171	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000309	0.0017	CcSEcCtD
Cefotaxime—Convulsion—Glyburide—type 2 diabetes mellitus	0.000309	0.0017	CcSEcCtD
Cefotaxime—Hepatitis—Metformin—type 2 diabetes mellitus	0.000308	0.00169	CcSEcCtD
Cefotaxime—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000305	0.00168	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000305	0.00167	CcSEcCtD
Cefotaxime—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000302	0.00166	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000302	0.00166	CcSEcCtD
Cefotaxime—Pain—Sitagliptin—type 2 diabetes mellitus	0.000301	0.00165	CcSEcCtD
Cefotaxime—Urticaria—Glipizide—type 2 diabetes mellitus	0.0003	0.00165	CcSEcCtD
Cefotaxime—Renal failure—Losartan—type 2 diabetes mellitus	0.000299	0.00164	CcSEcCtD
Cefotaxime—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000299	0.00164	CcSEcCtD
Cefotaxime—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000298	0.00164	CcSEcCtD
Cefotaxime—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000297	0.00163	CcSEcCtD
Cefotaxime—Jaundice—Losartan—type 2 diabetes mellitus	0.000297	0.00163	CcSEcCtD
Cefotaxime—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000295	0.00162	CcSEcCtD
Cefotaxime—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000292	0.00161	CcSEcCtD
Cefotaxime—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000291	0.0016	CcSEcCtD
Cefotaxime—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00029	0.0016	CcSEcCtD
Cefotaxime—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.00029	0.00159	CcSEcCtD
Cefotaxime—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.00029	0.00159	CcSEcCtD
Cefotaxime—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00029	0.00159	CcSEcCtD
Cefotaxime—Malaise—Gliclazide—type 2 diabetes mellitus	0.000289	0.00159	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000288	0.00158	CcSEcCtD
Cefotaxime—Rash—Repaglinide—type 2 diabetes mellitus	0.000288	0.00158	CcSEcCtD
Cefotaxime—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000288	0.00158	CcSEcCtD
Cefotaxime—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000288	0.00158	CcSEcCtD
Cefotaxime—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000288	0.00158	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000288	0.00158	CcSEcCtD
Cefotaxime—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000286	0.00157	CcSEcCtD
Cefotaxime—Headache—Repaglinide—type 2 diabetes mellitus	0.000286	0.00157	CcSEcCtD
Cefotaxime—Shock—Glyburide—type 2 diabetes mellitus	0.000286	0.00157	CcSEcCtD
Cefotaxime—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000285	0.00156	CcSEcCtD
Cefotaxime—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000284	0.00156	CcSEcCtD
Cefotaxime—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00028	0.00154	CcSEcCtD
Cefotaxime—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00153	CcSEcCtD
Cefotaxime—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000279	0.00153	CcSEcCtD
Cefotaxime—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000278	0.00153	CcSEcCtD
Cefotaxime—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000278	0.00153	CcSEcCtD
Cefotaxime—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000277	0.00152	CcSEcCtD
Cefotaxime—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000274	0.0015	CcSEcCtD
Cefotaxime—Hepatitis—Losartan—type 2 diabetes mellitus	0.000273	0.0015	CcSEcCtD
Cefotaxime—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000272	0.0015	CcSEcCtD
Cefotaxime—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000272	0.00149	CcSEcCtD
Cefotaxime—Nausea—Repaglinide—type 2 diabetes mellitus	0.000271	0.00149	CcSEcCtD
Cefotaxime—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00027	0.00149	CcSEcCtD
Cefotaxime—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00027	0.00148	CcSEcCtD
Cefotaxime—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000269	0.00148	CcSEcCtD
Cefotaxime—Angioedema—Valsartan—type 2 diabetes mellitus	0.000269	0.00148	CcSEcCtD
Cefotaxime—Pruritus—Glipizide—type 2 diabetes mellitus	0.000267	0.00147	CcSEcCtD
Cefotaxime—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000267	0.00147	CcSEcCtD
Cefotaxime—Angioedema—Orlistat—type 2 diabetes mellitus	0.000265	0.00146	CcSEcCtD
Cefotaxime—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000262	0.00144	CcSEcCtD
Cefotaxime—Malaise—Orlistat—type 2 diabetes mellitus	0.000262	0.00144	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00026	0.00143	CcSEcCtD
Cefotaxime—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00026	0.00143	CcSEcCtD
Cefotaxime—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000259	0.00142	CcSEcCtD
Cefotaxime—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000259	0.00142	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000259	0.00142	CcSEcCtD
Cefotaxime—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000259	0.00142	CcSEcCtD
Cefotaxime—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000258	0.00142	CcSEcCtD
Cefotaxime—Renal failure—Ramipril—type 2 diabetes mellitus	0.000256	0.00141	CcSEcCtD
Cefotaxime—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000256	0.00141	CcSEcCtD
Cefotaxime—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000256	0.0014	CcSEcCtD
Cefotaxime—Jaundice—Ramipril—type 2 diabetes mellitus	0.000254	0.0014	CcSEcCtD
Cefotaxime—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000253	0.00139	CcSEcCtD
Cefotaxime—Convulsion—Orlistat—type 2 diabetes mellitus	0.000252	0.00138	CcSEcCtD
Cefotaxime—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00138	CcSEcCtD
Cefotaxime—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00138	CcSEcCtD
Cefotaxime—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00025	0.00137	CcSEcCtD
Cefotaxime—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000248	0.00136	CcSEcCtD
Cefotaxime—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000248	0.00136	CcSEcCtD
Cefotaxime—Discomfort—Orlistat—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Cefotaxime—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Cefotaxime—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Cefotaxime—Malaise—Metformin—type 2 diabetes mellitus	0.000241	0.00133	CcSEcCtD
Cefotaxime—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000241	0.00133	CcSEcCtD
Cefotaxime—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00132	CcSEcCtD
Cefotaxime—Vomiting—Glipizide—type 2 diabetes mellitus	0.00024	0.00132	CcSEcCtD
Cefotaxime—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00024	0.00132	CcSEcCtD
Cefotaxime—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00024	0.00132	CcSEcCtD
Cefotaxime—Rash—Glipizide—type 2 diabetes mellitus	0.000238	0.00131	CcSEcCtD
Cefotaxime—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000238	0.00131	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000238	0.00131	CcSEcCtD
Cefotaxime—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000237	0.0013	CcSEcCtD
Cefotaxime—Headache—Glipizide—type 2 diabetes mellitus	0.000237	0.0013	CcSEcCtD
Cefotaxime—Shock—Valsartan—type 2 diabetes mellitus	0.000236	0.0013	CcSEcCtD
Cefotaxime—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000235	0.00129	CcSEcCtD
Cefotaxime—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000234	0.00129	CcSEcCtD
Cefotaxime—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000234	0.00129	CcSEcCtD
Cefotaxime—Urticaria—Glyburide—type 2 diabetes mellitus	0.000231	0.00127	CcSEcCtD
Cefotaxime—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000231	0.00127	CcSEcCtD
Cefotaxime—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00023	0.00126	CcSEcCtD
Cefotaxime—Malaise—Irbesartan—type 2 diabetes mellitus	0.000228	0.00125	CcSEcCtD
Cefotaxime—Headache—Pioglitazone—type 2 diabetes mellitus	0.000227	0.00125	CcSEcCtD
Cefotaxime—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000226	0.00124	CcSEcCtD
Cefotaxime—Discomfort—Metformin—type 2 diabetes mellitus	0.000225	0.00124	CcSEcCtD
Cefotaxime—Nausea—Glipizide—type 2 diabetes mellitus	0.000225	0.00123	CcSEcCtD
Cefotaxime—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000224	0.00123	CcSEcCtD
Cefotaxime—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000224	0.00123	CcSEcCtD
Cefotaxime—Pain—Gliclazide—type 2 diabetes mellitus	0.000223	0.00123	CcSEcCtD
Cefotaxime—Rash—Glimepiride—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Cefotaxime—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Cefotaxime—Rash—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Cefotaxime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00122	CcSEcCtD
Cefotaxime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000221	0.00122	CcSEcCtD
Cefotaxime—Headache—Glimepiride—type 2 diabetes mellitus	0.000221	0.00121	CcSEcCtD
Cefotaxime—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000221	0.00121	CcSEcCtD
Cefotaxime—Headache—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00121	CcSEcCtD
Cefotaxime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000218	0.0012	CcSEcCtD
Cefotaxime—Angioedema—Losartan—type 2 diabetes mellitus	0.000217	0.00119	CcSEcCtD
Cefotaxime—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000215	0.00118	CcSEcCtD
Cefotaxime—Shock—Metformin—type 2 diabetes mellitus	0.000215	0.00118	CcSEcCtD
Cefotaxime—Malaise—Losartan—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Cefotaxime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Cefotaxime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000214	0.00117	CcSEcCtD
Cefotaxime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000213	0.00117	CcSEcCtD
Cefotaxime—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000213	0.00117	CcSEcCtD
Cefotaxime—Nausea—Glimepiride—type 2 diabetes mellitus	0.00021	0.00115	CcSEcCtD
Cefotaxime—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000209	0.00115	CcSEcCtD
Cefotaxime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000209	0.00115	CcSEcCtD
Cefotaxime—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000207	0.00114	CcSEcCtD
Cefotaxime—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000206	0.00113	CcSEcCtD
Cefotaxime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000206	0.00113	CcSEcCtD
Cefotaxime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000206	0.00113	CcSEcCtD
Cefotaxime—Pruritus—Glyburide—type 2 diabetes mellitus	0.000206	0.00113	CcSEcCtD
Cefotaxime—Shock—Irbesartan—type 2 diabetes mellitus	0.000203	0.00111	CcSEcCtD
Cefotaxime—Pain—Orlistat—type 2 diabetes mellitus	0.000203	0.00111	CcSEcCtD
Cefotaxime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000202	0.00111	CcSEcCtD
Cefotaxime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000202	0.00111	CcSEcCtD
Cefotaxime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Cefotaxime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0002	0.0011	CcSEcCtD
Cefotaxime—Discomfort—Losartan—type 2 diabetes mellitus	0.0002	0.0011	CcSEcCtD
Cefotaxime—Headache—Bromocriptine—type 2 diabetes mellitus	0.000199	0.0011	CcSEcCtD
Cefotaxime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000199	0.00109	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000196	0.00108	CcSEcCtD
Cefotaxime—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Cefotaxime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000194	0.00107	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000194	0.00107	CcSEcCtD
Cefotaxime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000192	0.00106	CcSEcCtD
Cefotaxime—Shock—Losartan—type 2 diabetes mellitus	0.000191	0.00105	CcSEcCtD
Cefotaxime—Urticaria—Valsartan—type 2 diabetes mellitus	0.000191	0.00105	CcSEcCtD
Cefotaxime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00019	0.00104	CcSEcCtD
Cefotaxime—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00019	0.00104	CcSEcCtD
Cefotaxime—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Cefotaxime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000189	0.00104	CcSEcCtD
Cefotaxime—Urticaria—Orlistat—type 2 diabetes mellitus	0.000188	0.00103	CcSEcCtD
Cefotaxime—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000187	0.00103	CcSEcCtD
Cefotaxime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000187	0.00103	CcSEcCtD
Cefotaxime—Angioedema—Ramipril—type 2 diabetes mellitus	0.000186	0.00102	CcSEcCtD
Cefotaxime—Vomiting—Glyburide—type 2 diabetes mellitus	0.000185	0.00102	CcSEcCtD
Cefotaxime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000185	0.00102	CcSEcCtD
Cefotaxime—Malaise—Ramipril—type 2 diabetes mellitus	0.000184	0.00101	CcSEcCtD
Cefotaxime—Rash—Glyburide—type 2 diabetes mellitus	0.000183	0.00101	CcSEcCtD
Cefotaxime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000183	0.00101	CcSEcCtD
Cefotaxime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000183	0.001	CcSEcCtD
Cefotaxime—Headache—Glyburide—type 2 diabetes mellitus	0.000182	0.001	CcSEcCtD
Cefotaxime—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00018	0.000989	CcSEcCtD
Cefotaxime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000179	0.000982	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000179	0.000982	CcSEcCtD
Cefotaxime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000177	0.000971	CcSEcCtD
Cefotaxime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000177	0.000971	CcSEcCtD
Cefotaxime—Pain—Irbesartan—type 2 diabetes mellitus	0.000176	0.000969	CcSEcCtD
Cefotaxime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000175	0.00096	CcSEcCtD
Cefotaxime—Urticaria—Metformin—type 2 diabetes mellitus	0.000174	0.000954	CcSEcCtD
Cefotaxime—Nausea—Glyburide—type 2 diabetes mellitus	0.000173	0.000949	CcSEcCtD
Cefotaxime—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000173	0.000949	CcSEcCtD
Cefotaxime—Discomfort—Ramipril—type 2 diabetes mellitus	0.000172	0.000942	CcSEcCtD
Cefotaxime—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00017	0.000934	CcSEcCtD
Cefotaxime—Pruritus—Valsartan—type 2 diabetes mellitus	0.00017	0.000933	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000169	0.000926	CcSEcCtD
Cefotaxime—Pruritus—Orlistat—type 2 diabetes mellitus	0.000168	0.000922	CcSEcCtD
Cefotaxime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000166	0.000914	CcSEcCtD
Cefotaxime—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000166	0.000912	CcSEcCtD
Cefotaxime—Pain—Losartan—type 2 diabetes mellitus	0.000166	0.000912	CcSEcCtD
Cefotaxime—Rash—Gliclazide—type 2 diabetes mellitus	0.000165	0.000905	CcSEcCtD
Cefotaxime—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000165	0.000904	CcSEcCtD
Cefotaxime—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000164	0.000902	CcSEcCtD
Cefotaxime—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000164	0.0009	CcSEcCtD
Cefotaxime—Shock—Ramipril—type 2 diabetes mellitus	0.000164	0.000899	CcSEcCtD
Cefotaxime—Headache—Gliclazide—type 2 diabetes mellitus	0.000164	0.000899	CcSEcCtD
Cefotaxime—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000163	0.000896	CcSEcCtD
Cefotaxime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000163	0.000896	CcSEcCtD
Cefotaxime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000163	0.000895	CcSEcCtD
Cefotaxime—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000162	0.000891	CcSEcCtD
Cefotaxime—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00016	0.000879	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000159	0.000872	CcSEcCtD
Cefotaxime—Nausea—Gliclazide—type 2 diabetes mellitus	0.000155	0.000852	CcSEcCtD
Cefotaxime—Pruritus—Metformin—type 2 diabetes mellitus	0.000155	0.000849	CcSEcCtD
Cefotaxime—Urticaria—Losartan—type 2 diabetes mellitus	0.000154	0.000847	CcSEcCtD
Cefotaxime—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000153	0.000843	CcSEcCtD
Cefotaxime—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000153	0.000843	CcSEcCtD
Cefotaxime—Vomiting—Valsartan—type 2 diabetes mellitus	0.000153	0.000838	CcSEcCtD
Cefotaxime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000152	0.000835	CcSEcCtD
Cefotaxime—Rash—Valsartan—type 2 diabetes mellitus	0.000151	0.000831	CcSEcCtD
Cefotaxime—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000151	0.00083	CcSEcCtD
Cefotaxime—Vomiting—Orlistat—type 2 diabetes mellitus	0.000151	0.000828	CcSEcCtD
Cefotaxime—Headache—Valsartan—type 2 diabetes mellitus	0.00015	0.000826	CcSEcCtD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.00015	0.00549	CbGpPWpGaD
Cefotaxime—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00015	0.000821	CcSEcCtD
Cefotaxime—Rash—Orlistat—type 2 diabetes mellitus	0.00015	0.000821	CcSEcCtD
Cefotaxime—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000149	0.000821	CcSEcCtD
Cefotaxime—Headache—Orlistat—type 2 diabetes mellitus	0.000149	0.000816	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000148	0.00542	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000147	0.0054	CbGpPWpGaD
Cefotaxime—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000146	0.000802	CcSEcCtD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000144	0.0053	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000143	0.000786	CcSEcCtD
Cefotaxime—Nausea—Valsartan—type 2 diabetes mellitus	0.000143	0.000783	CcSEcCtD
Cefotaxime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000141	0.000775	CcSEcCtD
Cefotaxime—Nausea—Orlistat—type 2 diabetes mellitus	0.000141	0.000774	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00014	0.00512	CbGpPWpGaD
Cefotaxime—Vomiting—Metformin—type 2 diabetes mellitus	0.000139	0.000763	CcSEcCtD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000139	0.0051	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000138	0.00506	CbGpPWpGaD
Cefotaxime—Rash—Metformin—type 2 diabetes mellitus	0.000138	0.000757	CcSEcCtD
Cefotaxime—Cefradine—CYP3A4—type 2 diabetes mellitus	0.000138	0.0908	CrCbGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000138	0.00506	CbGpPWpGaD
Cefotaxime—Dermatitis—Metformin—type 2 diabetes mellitus	0.000138	0.000756	CcSEcCtD
Cefotaxime—Pruritus—Losartan—type 2 diabetes mellitus	0.000137	0.000754	CcSEcCtD
Cefotaxime—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000137	0.000753	CcSEcCtD
Cefotaxime—Headache—Metformin—type 2 diabetes mellitus	0.000137	0.000752	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000136	0.000748	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000136	0.00499	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000133	0.00488	CbGpPWpGaD
Cefotaxime—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000133	0.000729	CcSEcCtD
Cefotaxime—Urticaria—Ramipril—type 2 diabetes mellitus	0.000132	0.000726	CcSEcCtD
Cefotaxime—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000132	0.000723	CcSEcCtD
Cefotaxime—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000132	0.000723	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000131	0.00482	CbGpPWpGaD
Cefotaxime—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000131	0.00072	CcSEcCtD
Cefotaxime—Rash—Irbesartan—type 2 diabetes mellitus	0.00013	0.000714	CcSEcCtD
Cefotaxime—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00013	0.000714	CcSEcCtD
Cefotaxime—Nausea—Metformin—type 2 diabetes mellitus	0.00013	0.000713	CcSEcCtD
Cefotaxime—Headache—Irbesartan—type 2 diabetes mellitus	0.000129	0.00071	CcSEcCtD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000128	0.00471	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000127	0.00467	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000125	0.00459	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000124	0.00456	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000123	0.00453	CbGpPWpGaD
Cefotaxime—Vomiting—Losartan—type 2 diabetes mellitus	0.000123	0.000678	CcSEcCtD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000123	0.00451	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000123	0.000674	CcSEcCtD
Cefotaxime—Nausea—Irbesartan—type 2 diabetes mellitus	0.000122	0.000673	CcSEcCtD
Cefotaxime—Rash—Losartan—type 2 diabetes mellitus	0.000122	0.000672	CcSEcCtD
Cefotaxime—Dermatitis—Losartan—type 2 diabetes mellitus	0.000122	0.000672	CcSEcCtD
Cefotaxime—Headache—Losartan—type 2 diabetes mellitus	0.000122	0.000668	CcSEcCtD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000121	0.00443	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000118	0.00434	CbGpPWpGaD
Cefotaxime—Pruritus—Ramipril—type 2 diabetes mellitus	0.000118	0.000647	CcSEcCtD
Cefotaxime—Nausea—Losartan—type 2 diabetes mellitus	0.000115	0.000633	CcSEcCtD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000115	0.00423	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000114	0.00419	CbGpPWpGaD
Cefotaxime—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000114	0.000626	CcSEcCtD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000111	0.00406	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000109	0.00399	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000107	0.00393	CbGpPWpGaD
Cefotaxime—Vomiting—Ramipril—type 2 diabetes mellitus	0.000106	0.000581	CcSEcCtD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000106	0.00388	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000105	0.00386	CbGpPWpGaD
Cefotaxime—Rash—Ramipril—type 2 diabetes mellitus	0.000105	0.000576	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000105	0.00385	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000105	0.00385	CbGpPWpGaD
Cefotaxime—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000105	0.000576	CcSEcCtD
Cefotaxime—Headache—Ramipril—type 2 diabetes mellitus	0.000104	0.000573	CcSEcCtD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000104	0.0038	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000103	0.00379	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000103	0.00378	CbGpPWpGaD
Cefotaxime—Cefazolin—ALB—type 2 diabetes mellitus	0.000103	0.0679	CrCbGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000102	0.00375	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000101	0.00372	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.0001	0.00369	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.0001	0.00368	CbGpPWpGaD
Cefotaxime—Nausea—Ramipril—type 2 diabetes mellitus	9.88e-05	0.000543	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.85e-05	0.00362	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	9.76e-05	0.00358	CbGpPWpGaD
Cefotaxime—Ceftriaxone—ALB—type 2 diabetes mellitus	9.76e-05	0.0644	CrCbGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	9.69e-05	0.00356	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	9.69e-05	0.00356	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	9.59e-05	0.00352	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	9.58e-05	0.00352	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	9.52e-05	0.0035	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	9.51e-05	0.00349	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	9.51e-05	0.00349	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	9.49e-05	0.00348	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	9.35e-05	0.00344	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.31e-05	0.00342	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	9.06e-05	0.00333	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8.99e-05	0.0033	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8.99e-05	0.0033	CbGpPWpGaD
Cefotaxime—Cephalexin—CYP3A4—type 2 diabetes mellitus	8.91e-05	0.0588	CrCbGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.86e-05	0.00325	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	8.84e-05	0.00325	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	8.76e-05	0.00322	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.7e-05	0.0032	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	8.57e-05	0.00315	CbGpPWpGaD
Cefotaxime—Cefalotin—ALB—type 2 diabetes mellitus	8.55e-05	0.0564	CrCbGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	8.55e-05	0.00314	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	8.55e-05	0.00314	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	8.46e-05	0.00311	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.44e-05	0.0031	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	8.28e-05	0.00304	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	8.23e-05	0.00302	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	8.23e-05	0.00302	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.22e-05	0.00302	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	8.21e-05	0.00302	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	8.08e-05	0.00297	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	8.06e-05	0.00296	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8e-05	0.00294	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8e-05	0.00294	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	7.92e-05	0.00291	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.9e-05	0.0029	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.9e-05	0.0029	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.86e-05	0.00289	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	7.77e-05	0.00286	CbGpPWpGaD
Cefotaxime—Cephalexin—ALB—type 2 diabetes mellitus	7.77e-05	0.0513	CrCbGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.76e-05	0.00285	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.76e-05	0.00285	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.6e-05	0.00279	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.6e-05	0.00279	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	7.59e-05	0.00279	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	7.47e-05	0.00274	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.47e-05	0.00274	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.47e-05	0.00274	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.47e-05	0.00274	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	7.45e-05	0.00274	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	7.35e-05	0.0027	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.33e-05	0.00269	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.33e-05	0.00269	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.33e-05	0.00269	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.31e-05	0.00269	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.05e-05	0.00259	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.05e-05	0.00259	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	7.04e-05	0.00259	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	7.04e-05	0.00259	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	7e-05	0.00257	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.98e-05	0.00257	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.93e-05	0.00255	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	6.91e-05	0.00254	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.9e-05	0.00254	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.78e-05	0.00249	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.76e-05	0.00248	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	6.72e-05	0.00247	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	6.67e-05	0.00245	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	6.67e-05	0.00245	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	6.56e-05	0.00241	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.53e-05	0.0024	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.52e-05	0.00239	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.52e-05	0.00239	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.48e-05	0.00238	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.46e-05	0.00237	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.45e-05	0.00237	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.41e-05	0.00235	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.35e-05	0.00233	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.34e-05	0.00233	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.27e-05	0.0023	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.27e-05	0.0023	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.26e-05	0.0023	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.24e-05	0.00229	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.16e-05	0.00226	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.13e-05	0.00225	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	6.1e-05	0.00224	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6e-05	0.0022	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.99e-05	0.0022	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.98e-05	0.0022	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.88e-05	0.00216	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.79e-05	0.00213	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.7e-05	0.00209	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.62e-05	0.00206	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.55e-05	0.00204	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	5.45e-05	0.002	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.44e-05	0.002	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.44e-05	0.002	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.37e-05	0.00197	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.37e-05	0.00197	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.34e-05	0.00196	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.33e-05	0.00196	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.24e-05	0.00192	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.24e-05	0.00192	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.24e-05	0.00192	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	5.23e-05	0.00192	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.21e-05	0.00191	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.19e-05	0.00191	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.18e-05	0.0019	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.15e-05	0.00189	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.14e-05	0.00189	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.1e-05	0.00187	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.96e-05	0.00182	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.96e-05	0.00182	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.94e-05	0.00181	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.87e-05	0.00179	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.87e-05	0.00179	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.84e-05	0.00178	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.82e-05	0.00177	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.81e-05	0.00177	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.78e-05	0.00176	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	4.76e-05	0.00175	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.75e-05	0.00175	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.73e-05	0.00174	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.7e-05	0.00173	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.6e-05	0.00169	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.6e-05	0.00169	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.56e-05	0.00168	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.49e-05	0.00165	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.47e-05	0.00164	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.45e-05	0.00164	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	4.45e-05	0.00163	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.44e-05	0.00163	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.35e-05	0.0016	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.3e-05	0.00158	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.29e-05	0.00157	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.23e-05	0.00155	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.22e-05	0.00155	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.17e-05	0.00153	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.14e-05	0.00152	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.12e-05	0.00151	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.09e-05	0.0015	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.09e-05	0.0015	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.02e-05	0.00148	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4e-05	0.00147	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.97e-05	0.00146	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.95e-05	0.00145	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.95e-05	0.00145	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.91e-05	0.00144	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.91e-05	0.00144	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.86e-05	0.00142	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.84e-05	0.00141	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.79e-05	0.00139	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.73e-05	0.00137	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.63e-05	0.00133	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.6e-05	0.00132	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.58e-05	0.00132	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.58e-05	0.00131	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.58e-05	0.00131	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.55e-05	0.0013	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.48e-05	0.00128	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.43e-05	0.00126	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.42e-05	0.00125	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.42e-05	0.00125	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.33e-05	0.00122	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.32e-05	0.00122	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.32e-05	0.00122	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.32e-05	0.00122	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.31e-05	0.00122	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.3e-05	0.00121	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.28e-05	0.0012	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.26e-05	0.0012	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.25e-05	0.00119	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.23e-05	0.00119	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.22e-05	0.00118	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.21e-05	0.00118	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.18e-05	0.00117	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.17e-05	0.00116	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.11e-05	0.00114	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.08e-05	0.00113	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.07e-05	0.00113	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.04e-05	0.00112	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.96e-05	0.00109	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.94e-05	0.00108	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.91e-05	0.00107	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.9e-05	0.00107	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.89e-05	0.00106	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.77e-05	0.00102	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.75e-05	0.00101	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.74e-05	0.00101	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.73e-05	0.001	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.71e-05	0.000997	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.71e-05	0.000994	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.69e-05	0.000989	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.67e-05	0.000982	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.66e-05	0.000976	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.63e-05	0.000964	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.62e-05	0.000961	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.51e-05	0.000921	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.48e-05	0.000911	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.46e-05	0.000904	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.45e-05	0.000898	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.33e-05	0.000855	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.29e-05	0.000841	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.28e-05	0.000837	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.26e-05	0.00083	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.21e-05	0.00081	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.18e-05	0.000802	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.15e-05	0.00079	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.07e-05	0.00076	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.04e-05	0.00075	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.99e-05	0.00073	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.95e-05	0.000717	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.84e-05	0.000677	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.84e-05	0.000676	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.73e-05	0.000634	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.64e-05	0.000602	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.37e-05	0.000503	CbGpPWpGaD
